易利华:谈谈区域医疗集团与医联体协同机制的研究

2017-09-06 易利华 健康界

近年来,各地在医改中有一个重要的任务,就是要开展对区域内的医疗卫生资源进行重新配置和最佳应用的研究。在实践工作中,比较多见的形式有区域医疗集团、医疗联合体、托管帮扶以及对口支援下级医疗机构等。

近年来,各地在医改中有一个重要的任务,就是要开展对区域内的医疗卫生资源进行重新配置和最佳应用机制的研究。在实践工作中,比较多见的形式有区域医疗集团、医疗联合体、托管帮扶以及对口支援下级医疗机构等形式。在这些改革的组织形式过程中,大家普遍对其中一种专项改革组织形式的应用研究关注得比较多,而对于几种改革组织形式之间的并存和协同机制的研究则相对很少,或者说几乎没有。在此,我们提出自己的几点研究思路,供关注者思考。

第一,区域医疗集团应当从现代医院管理制度的组织架构和体系的应用研究入手。

我们应当以一、二级法人的组织形式,重新构建医疗集团的各种要素和资源的配置,重构医疗服务的组织、形式和架构,以集团内部的资源优化和资源互补来实现集团化改革的目标。这其中主要的研究课题应当有:

一是集团化的法人治理结构究竟应当如何构建?

二是集团内的要素资源究竟应当如何配置?

三是集团内部科学的绩效分配和效益分享的体系与机制究竟应当如何构建和实施?

四是集团内的人力资源、资产资源和品牌资源等究竟应当如何实现最佳组合与合理流动,以提高集团内部各家医院的整体组织效能?

第二,要探讨具有生命力的紧密型医联体的构建。

如果说区域内的集团化改革主要是针对同一区域、同一层次的医疗机构改革采用较多的话!那么医联体的改革则更多地是跨区域、跨级别和多种形式并存的一种医疗组织改革方式。在此,我们比较推崇的是构建具有生命力的紧密型医疗联合体。也就是说上级医院以核心医院的形式对下级医疗机构和基层医疗机构实行一定程度上的统一管理。如:可以实行联合经营、派驻法人代表、主要管理者整体托管以及医联体内部具有一定的人员调配和资源共享的管理方式等。在紧密型医联体的建设中,我们要实现三个目标:

一是双赢的目标。上下级医院都能得益,才能真正的持久的结合。

二是优化医疗服务的目标。通过医联体的改革,要使两家医院的医疗服务得到互补和优化。

三是实现双向转诊的目标。医联体内部必须建立严格有序和科学的双向转诊制度,复杂与特殊病人必须及时上转,康复和常见病的病人必须下转。只有这样,紧密型医疗联合体的改革,才能象几乎一个医疗机构一样的运作,才能有生命力、创新力和价值。

第三,要注重区域集团化改革与紧密型医联体协同机制的研究。

事实上,在一个区域内,医院改革的方式方法和组织形式可能是多种多样的。有集团化改革,有医联体改革,有托管帮扶式的改革等。对于三级甲等医院来说,我们要面对多种改革组织形式的并存,并且注重发挥其不同的管理作用。在此我们提出关于集团化改革和医联体改革协同机制研究的新方向,这里面要解决三个问题:一是什么样的医院之间适合采用集团化改革的方式和机制?二是采用什么科学的管理方式来组建紧密型的医疗联合体?三是怎样运用托管帮扶的方法,合理配置医疗资源,建立多种形式的改革机制?对于医院改革中多种组织形式的并存、协同和提升效能。

在这方面我们提出三点认识:

一是要注重核心医院优质医疗的同质化管理运用和输出。这很重要,也是第一前提。有些医院改革没有输出同质化的医疗形式、管理与优质医疗服务和技术,使得改革只有其名没有其实,这是不成功的。

二是要实现医疗资源的最优配置和合理流动。医疗组织机构的改革,其目的就是要搭建一个全新的组织与机制的创新平台,在这个全新的平台里,能比原先的体制和机制具有更强的活力和更佳的整体效应。

三是改革不能搞均贫富,不能淡化、弱化核心医院优质医疗资源的引领和管理作用,否则这样的改革就会被稀释,就会被弱化,就会导致落后,就会失去改革与创新的价值和动力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748041, encodeId=c6b21e4804166, content=<a href='/topic/show?id=50453520661' target=_blank style='color:#2F92EE;'>#医疗集团#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35206, encryptionId=50453520661, topicName=医疗集团)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jan 15 19:34:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242826, encodeId=65fb2428265d, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 11 10:35:24 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335614, encodeId=cb7e133561485, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Fri Sep 08 01:34:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241407, encodeId=544524140e24, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Sep 07 09:20:17 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241028, encodeId=56b22410289b, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/07/5fd7f6b597acf767e8c3c43ef0485c3f.jpg, createdBy=a1252104908, createdName=金戈铁马, createdTime=Wed Sep 06 11:43:59 CST 2017, time=2017-09-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748041, encodeId=c6b21e4804166, content=<a href='/topic/show?id=50453520661' target=_blank style='color:#2F92EE;'>#医疗集团#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35206, encryptionId=50453520661, topicName=医疗集团)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jan 15 19:34:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242826, encodeId=65fb2428265d, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 11 10:35:24 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335614, encodeId=cb7e133561485, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Fri Sep 08 01:34:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241407, encodeId=544524140e24, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Sep 07 09:20:17 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241028, encodeId=56b22410289b, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/07/5fd7f6b597acf767e8c3c43ef0485c3f.jpg, createdBy=a1252104908, createdName=金戈铁马, createdTime=Wed Sep 06 11:43:59 CST 2017, time=2017-09-06, status=1, ipAttribution=)]
    2017-09-11 大爰

    学习并分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1748041, encodeId=c6b21e4804166, content=<a href='/topic/show?id=50453520661' target=_blank style='color:#2F92EE;'>#医疗集团#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35206, encryptionId=50453520661, topicName=医疗集团)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jan 15 19:34:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242826, encodeId=65fb2428265d, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 11 10:35:24 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335614, encodeId=cb7e133561485, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Fri Sep 08 01:34:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241407, encodeId=544524140e24, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Sep 07 09:20:17 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241028, encodeId=56b22410289b, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/07/5fd7f6b597acf767e8c3c43ef0485c3f.jpg, createdBy=a1252104908, createdName=金戈铁马, createdTime=Wed Sep 06 11:43:59 CST 2017, time=2017-09-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748041, encodeId=c6b21e4804166, content=<a href='/topic/show?id=50453520661' target=_blank style='color:#2F92EE;'>#医疗集团#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35206, encryptionId=50453520661, topicName=医疗集团)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jan 15 19:34:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242826, encodeId=65fb2428265d, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 11 10:35:24 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335614, encodeId=cb7e133561485, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Fri Sep 08 01:34:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241407, encodeId=544524140e24, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Sep 07 09:20:17 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241028, encodeId=56b22410289b, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/07/5fd7f6b597acf767e8c3c43ef0485c3f.jpg, createdBy=a1252104908, createdName=金戈铁马, createdTime=Wed Sep 06 11:43:59 CST 2017, time=2017-09-06, status=1, ipAttribution=)]
    2017-09-07 明天会更好!

    学习了很有用不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1748041, encodeId=c6b21e4804166, content=<a href='/topic/show?id=50453520661' target=_blank style='color:#2F92EE;'>#医疗集团#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35206, encryptionId=50453520661, topicName=医疗集团)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jan 15 19:34:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242826, encodeId=65fb2428265d, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 11 10:35:24 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335614, encodeId=cb7e133561485, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Fri Sep 08 01:34:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241407, encodeId=544524140e24, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Sep 07 09:20:17 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241028, encodeId=56b22410289b, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/07/5fd7f6b597acf767e8c3c43ef0485c3f.jpg, createdBy=a1252104908, createdName=金戈铁马, createdTime=Wed Sep 06 11:43:59 CST 2017, time=2017-09-06, status=1, ipAttribution=)]
    2017-09-06 金戈铁马

    不错

    0

相关资讯

医生集团风光无限的背后是身份的尴尬

在医疗需求快速增加、国家逐步放开医生多点执业的大环境下,医生集团如雨后春笋般在中国破土而生。这个时下很“火”的执业模式吸引了不少体制内外医生的加入。不断增加的数量和资本令医生集团风光无限,但不少业内人士指出,实际情况并非那么简单,医生集团存在身份尴尬,长此发展下去恐非长久之计。 近一段时间以来,医生集团成为医疗圈的热点。仅在今年,新成立的医生集团就超过20家。数量增加的同时,医生集团筹资

又一个**医改样板要全国推广了!

9月1日,国务院医改办在深圳举行全国医联体建设现场推进会,全国32个省、自治区、直辖市近300名医改干部齐聚深圳上课学习,国家卫计委主任李斌,国家卫计委副主任、国务院医改办主任王贺胜出席。

山西推行“医疗集团+”一体化改革

近日,山西省政府召开全面推行县乡医疗卫生机构一体化改革工作电视电话会议,山西省省长楼阳生出席会议并作重要讲话,山西省委常委、常务副省长高建民主持会议,山西省政协副主席、省卫生计生委主任卫小春通报改革试点进展情况。